Exobiosphere, the space biotechnology company advancing

Exobiosphere，一家推动太空生物技术发展的公司

drug discovery

药物发现

and

和

biomedical research

生物医学研究

in

在

microgravity

微重力

, has secured €1 million in non-dilutive

，已获得100万欧元的非稀释性资金

funding

资金

through Luxembourg's Jeune Entreprise Innovante (JEI) aid, administered by the Ministry of the Economy .

通过卢森堡经济部管理的“年轻创新企业”（JEI）援助计划。

The funding will accelerate the company's commercial expansion, strengthen operations, grow its international business development and marketing activities, while supporting the scale-up of Exobiosphere's proprietary orbital high-throughput screening platform. The aid for young innovative enterprise was conditional to an innovation certificate by Luxinnovation..

这笔资金将加速公司的商业扩张，加强运营，拓展国际业务开发和营销活动，同时支持Exobiosphere专有的轨道高通量筛选平台的规模化发展。对年轻创新企业的援助以获得Luxinnovation颁发的创新证书为前提条件。

The JEIaid supports young, research-intensive companies with strong growth potential by providing non-dilutive funding alongside private investment. Designed to help innovative businesses transition into their next phase of growth, the aid enables companies to accelerate development, strengthen commercial activities and expand internationally..

JEIaid通过提供非稀释性资金并结合私人投资，支持具有强大增长潜力的年轻、研发密集型企业。该援助旨在帮助创新企业过渡到下一阶段的成长，使企业能够加速开发、加强商业活动并拓展国际市场。

'This grant lands at exactly the right moment and makes a real difference for a company at our stage. It allows us to expand our commercial activities, strengthen our team, and bring our technological offer to more pharmaceutical and biotech partners around the world. We're grateful for the continued support of the Luxembourg innovation ecosystem and Ministry of Economy.' said Kyle Acierno, CEO and Co-Founder of Exobiosphere ..

“这笔拨款来得正是时候，对我们这样发展阶段的公司产生了切实的影响。它使我们能够扩大商业活动，加强团队建设，并将我们的技术方案推广给全球更多的制药和生物技术合作伙伴。我们感谢卢森堡创新生态系统和经济部持续给予的支持。”Exobiosphere 首席执行官兼联合创始人凯尔·阿奇尔诺（Kyle Acierno）表示。

This grant will reinforce’s Exobiosphere's position as one of world’s fastest- growing space biotechnology companies and reflect Luxembourg's commitment to supporting world-class innovation at the intersection of biotechnology and space.

这笔资助将巩固Exobiosphere作为全球增长最快的太空生物技术公司之一的地位，并体现卢森堡对支持生物技术与太空交叉领域世界级创新的承诺。

https://www.bionity.com/en/news/1189590/space-biotech-startup-exobiosphere-secures-1-million-grant.html

https://www.bionity.com/en/news/1189590/space-biotech-startup-exobiosphere-secures-1-million-grant.html

Next-generation AI drug design engine

下一代人工智能药物设计引擎

Isomorphic Labs announces $600m external investment round

Isomorphic Labs 宣布完成 6 亿美元外部融资

Read news

阅读新闻

Most read news

阅读最多的新闻

1

1

MicroHarvest is building Europe's first industrial facility for microbial protein at the Leuna Chemical Park

MicroHarvest 正在莱纳化学公园建设欧洲首个微生物蛋白工业设施

2

2

Scientists turn COVID-19 immune memory into a powerful new ally against cancer

科学家将新冠免疫记忆转化为对抗癌症的强大新盟友

3

3

Europe: Conflicting Laws Threaten Biodiversity and Food Security

欧洲：相互冲突的法律威胁生物多样性和粮食安全

4

4

Visugromab Overcomes Resistance to Cancer Immunotherapy

Visugromab克服癌症免疫治疗的耐药性

5

5

Peptide isolated from a Cerrado frog increases strawberry shelf life

从塞拉多青蛙中分离出的肽可延长草莓的保质期

Topics

主题

microgravity

微重力

drug discovery

药物发现

biomedical research

生物医学研究

funding

资金

high-throughput screening

高通量筛选

Show all

显示全部

Show less

显示更少

Organizations

组织

Exobiosphere

外生物圈